Search details
1.
Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression.
Clin Gastroenterol Hepatol
; 2024 Feb 28.
Article
in English
| MEDLINE | ID: mdl-38428709
2.
Gut Microbiome Composition Is Associated With Future Onset of Crohn's Disease in Healthy First-Degree Relatives.
Gastroenterology
; 165(3): 670-681, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37263307
3.
Environmental Factors Associated with Risk of Crohn's Disease Development in the CCC-GEM Project.
Clin Gastroenterol Hepatol
; 2024 May 15.
Article
in English
| MEDLINE | ID: mdl-38759825
4.
Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naïve Crohn's Disease.
Am J Gastroenterol
; 2024 Feb 09.
Article
in English
| MEDLINE | ID: mdl-38235763
5.
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 21(4): 1050-1060.e9, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36029969
6.
Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early Responders.
Clin Gastroenterol Hepatol
; 21(13): 3387-3396.e1, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37391059
7.
Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's Disease.
Gastroenterology
; 163(5): 1364-1376.e10, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35850197
8.
Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation.
Gastroenterology
; 163(3): 685-698, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35643175
9.
Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study.
Clin Gastroenterol Hepatol
; 21(10): 2649-2659.e16, 2023 09.
Article
in English
| MEDLINE | ID: mdl-36528284
10.
Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY Study.
Am J Gastroenterol
; 118(1): 121-128, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-36066459
11.
Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's Disease.
J Clin Gastroenterol
; 57(9): 913-919, 2023 10 01.
Article
in English
| MEDLINE | ID: mdl-36227009
12.
End of induction patient reported outcomes predict clinical remission and endoscopic improvement with vedolizumab and adalimumab in ulcerative colitis.
Scand J Gastroenterol
; 58(1): 7-14, 2023 01.
Article
in English
| MEDLINE | ID: mdl-35909369
13.
Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission.
Dig Dis Sci
; 68(6): 2658-2666, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36645636
14.
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study.
Dig Dis Sci
; 68(6): 2635-2646, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37119375
15.
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(7): 1588-1597.e3, 2022 07.
Article
in English
| MEDLINE | ID: mdl-34329776
16.
Early Change in Epithelial Neutrophilic Infiltrate Predicts Long-Term Response to Biologics in Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(5): 1095-1104.e9, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34229037
17.
Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn's Disease.
Clin Gastroenterol Hepatol
; 20(7): 1579-1587.e2, 2022 07.
Article
in English
| MEDLINE | ID: mdl-33838348
18.
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
Gastroenterology
; 161(2): 681-700, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34334167
19.
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines.
Gastroenterology
; 161(2): 669-680.e0, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33617891
20.
Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease.
Am J Gastroenterol
; 117(7): 1106-1117, 2022 07 01.
Article
in English
| MEDLINE | ID: mdl-35435862